FDA Approves Polypill Widaplik for Hypertension
Physician's Weekly
JUNE 11, 2025
The FDA approval is based on positive results from two international phase 3 trials that compared Widaplik to dual combinations of its component drugs as well as to placebo. ” The approval of Widaplik was granted to George Medicines. More Information Copyright © 2025 HealthDay. All rights reserved.
Let's personalize your content